Symbols / DMII Stock $10.01 +0.00% Drugs Made In America Acquisition II Corp.

Financial Services • Shell Companies • United States • NGM
DMII (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Stock Fundamentals
Scroll to Statements
Market Cap 637.64M Enterprise Value 637.64M Income 4.19M Sales — Book/sh -0.26 Cash/sh 223.00
Dividend Yield — Payout 0.00% Employees — IPO — P/E 66.73 Forward P/E —
PEG — P/S — P/B -37.92 P/C — EV/EBITDA — EV/Sales —
Quick Ratio 0.00 Current Ratio 0.09 Debt/Eq — LT Debt/Eq — EPS (ttm) 0.15 EPS next Y —
EPS Growth — Revenue Growth — Earnings — ROA -0.32% ROE — ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 63.70M Shs Float 50.64M Short Float 0.07%
Short Ratio 0.47 Short Interest — 52W High 10.01 52W Low 9.86 Beta — Avg Volume 101.76K
Volume 386.37K Target Price — Recom None Prev Close $10.01 Price $10.01 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$10.01
Latest analyst target
3. DCF / Fair value
$-0.14
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.01
Low
—
High
—
Mean
—
News
RSS: Latest DMII news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31
Total Revenue
0.00
Operating Revenue
0.00
Operating Expense
1.30
Selling General And Administration
0.49
General And Administrative Expense
0.49
Other Gand A
0.49
Total Expenses
1.30
Operating Income
-1.30
Total Operating Income As Reported
-0.49
EBITDA
-1.30
Normalized EBITDA
-1.85
EBIT
-1.30
Total Unusual Items
0.55
Total Unusual Items Excluding Goodwill
0.55
Special Income Charges
0.55
Other Special Charges
-0.55
Net Income
4.19
Pretax Income
4.19
Net Non Operating Interest Income Expense
4.93
Net Interest Income
4.93
Interest Income Non Operating
4.93
Interest Income
4.93
Other Income Expense
0.55
Tax Rate For Calcs
0.00
Tax Effect Of Unusual Items
0.12
Net Income Including Noncontrolling Interests
4.19
Net Income From Continuing Operation Net Minority Interest
4.19
Net Income From Continuing And Discontinued Operation
4.19
Net Income Continuous Operations
4.19
Normalized Income
3.75
Net Income Common Stockholders
4.19
Diluted NI Availto Com Stockholders
4.19
Provision For Doubtful Accounts
0.81
Line Item Trend 2025-12-31 2024-12-31
Total Assets
504.96
+365643.31%
0.14
Current Assets
0.03
-56.32%
0.06
Cash Cash Equivalents And Short Term Investments
0.00
-98.69%
0.02
Cash And Cash Equivalents
0.00
-98.69%
0.02
Cash Financial
0.00
-98.69%
0.02
Receivables
0.00
0.00
Prepaid Assets
0.03
-39.38%
0.04
Total Non Current Assets
504.93
+643545.94%
0.08
Non Current Deferred Assets
0.00
-100.00%
0.08
Other Non Current Assets
504.93
—
Total Liabilities Net Minority Interest
17.80
+6886.68%
0.25
Current Liabilities
0.30
+18.09%
0.25
Payables And Accrued Expenses
0.30
+6324.60%
0.00
Payables
0.10
—
Accounts Payable
0.10
0.00
Current Accrued Expenses
0.20
+4202.90%
0.00
Current Debt And Capital Lease Obligation
—
0.25
Current Debt
—
0.25
Other Current Borrowings
—
0.25
Total Non Current Liabilities Net Minority Interest
17.50
0.00
Tradeand Other Payables Non Current
17.50
0.00
Stockholders Equity
487.16
+417477.61%
-0.12
Common Stock Equity
487.16
+417477.61%
-0.12
Capital Stock
504.94
+35138046.76%
0.00
Common Stock
504.94
+35138046.76%
0.00
Preferred Stock
0.00
0.00
Share Issued
63.70
+0.00%
63.70
Ordinary Shares Number
63.70
+0.00%
63.70
Additional Paid In Capital
0.00
-100.00%
0.03
Retained Earnings
-17.78
-11616.53%
-0.15
Total Equity Gross Minority Interest
487.16
+417477.61%
-0.12
Total Capitalization
487.16
+417477.61%
-0.12
Working Capital
-0.27
-40.82%
-0.20
Invested Capital
487.16
+365138.66%
0.13
Total Debt
—
0.25
Net Debt
—
0.23
Net Tangible Assets
487.16
+417477.61%
-0.12
Tangible Book Value
487.16
+417477.61%
-0.12
Duefrom Related Parties Current
0.00
0.00
Line Item Trend 2025-12-31
Operating Cash Flow
-1.02
Cash Flow From Continuing Operating Activities
-1.02
Net Income From Continuing Operations
4.19
Other Non Cash Items
-4.86
Provisionand Write Offof Assets
0.81
Operating Gains Losses
-0.55
Change In Working Capital
-0.61
Change In Receivables
-0.81
Change In Prepaid Assets
0.02
Change In Payables And Accrued Expense
0.19
Change In Accrued Expense
0.09
Change In Payable
0.10
Change In Account Payable
0.10
Investing Cash Flow
-500.00
Cash Flow From Continuing Investing Activities
-500.00
Net Investment Purchase And Sale
-500.00
Purchase Of Investment
-500.00
Financing Cash Flow
501.00
Cash Flow From Continuing Financing Activities
501.00
Net Issuance Payments Of Debt
-0.53
Issuance Of Debt
0.00
Repayment Of Debt
-0.53
Short Term Debt Issuance
0.00
Short Term Debt Payments
-0.53
Net Short Term Debt Issuance
-0.53
Net Common Stock Issuance
502.00
Net Other Financing Charges
-0.46
Changes In Cash
-0.02
Beginning Cash Position
0.02
End Cash Position
0.00
Free Cash Flow
-1.02
Common Stock Issuance
502.00
Issuance Of Capital Stock
502.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category